Investig Clin Urol.
2016 Mar;57(2):73-74. 10.4111/icu.2016.57.2.73.
Biomarkers for bladder cancer: The search continues!
- Affiliations
-
- 1Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea. skhong@snubh.org
- KMID: 2363127
- DOI: http://doi.org/10.4111/icu.2016.57.2.73
Abstract
- No abstract available.
Reference
-
1. Kim YH, Yan C, Lee IS, Piao XM, Byun YJ, Jeong P, et al. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer. Investig Clin Urol. 2016; 57:106–112.2. Kim EJ, Lee YS, Kim YJ, Kim MJ, Ha YS, Jeong P, et al. Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer. Urology. 2010; 75:1516.e9. 1516.e13.3. Schmitz-Drager BJ, Droller M, Lokeshwar VB, Lotan Y, Hudson MA, van Rhijn BW, et al. Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus. Urol Int. 2015; 94:1–24.
